GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) » Definitions » 3-Year EBITDA Growth Rate

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) 3-Year EBITDA Growth Rate : 12.40% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Anhui Fengyuan Pharmaceutical Co 3-Year EBITDA Growth Rate?

Anhui Fengyuan Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.22.

During the past 12 months, Anhui Fengyuan Pharmaceutical Co's average EBITDA Per Share Growth Rate was -2.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Anhui Fengyuan Pharmaceutical Co was 17.80% per year. The lowest was -3.10% per year. And the median was 8.90% per year.


Competitive Comparison of Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.



Anhui Fengyuan Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Anhui Fengyuan Pharmaceutical Co  (SZSE:000153) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Anhui Fengyuan Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Anhui Fengyuan Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Business Description

Traded in Other Exchanges
N/A
Address
No. 108, Beimenwai Street, Wuwei County, Anhui Province, Hefei, CHN, 230051
Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.
Executives
Li Guo Kun Executives

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Headlines

No Headlines